ADIPOQ and Hepatic fibrosis: Additionally, these results may encourage the designing of diagnostic accuracy studies to examine whether plasma adiponectin levels may contribute (alone or in combination with other biomarkers) to the achievement of a non-invasive diagnosis of liver fibrosis.